BLUE WATER LIFE SCIENCE ADVISORS LP
Q2 2023 Form 13-F
LARKSPUR, CALIFORNIA
CIK 0001789778
· CRD 306450
· SEC-registered investment adviser
$148.2M Reported Value Total
BLUE WATER LIFE SCIENCE ADVISORS, LP reports 5 total accounts under management (AUM). There are 5 discretionary accounts valued at $231,380,370, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
6 funds
· $330.0M gross asset value
Hedge Fund: $318.2M · Private Equity Fund: $11.8M
Source: Form ADV filed 2026-03-26
Reported value
$148.2M
Quarter over quarter
-9.4%
Holdings
7
Top-10 concentration
100.0%
Key People
Form ADV owners & control persons
Nathaniel Thomas Cornell
PORTFOLIO MANAGER AND MANAGING MEMBER AND CHIEF COMPLIANCE OFFICER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q2 2023 13F record
Q2 2023 13F filing summary
| Period of report | June 30, 2023 |
|---|---|
| Filed | August 14, 2023 |
| Form | 13F-HR |
| Reported value | $148.2M |
| Positions | 7 |
| Change in reported value | -2.0% |
| New positions | 1 |
| Exited positions | 2 |
| Position turnover | 33.3% |
| Top-10 concentration | 100.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 13, 2026
|
8 | $251.6M |
|
Q2 2026 13F
Filed Aug 14, 2026
|
9 | $158.8M |
|
Q1 2026 13F
Filed May 14, 2026
|
10 | $124.7M |
|
Q4 2025 13F
Filed Feb 17, 2026
|
9 | $159.3M |
|
Q3 2025 13F
Filed Nov 14, 2025
|
7 | $109.6M |
|
Q2 2025 13F
Filed Aug 14, 2025
|
8 | $126.3M |
|
Q1 2025 13F
Filed May 15, 2025
|
7 | $100.9M |
|
Q4 2024 13F
Filed Feb 13, 2025
|
9 | $112.9M |
|
Q3 2024 13F
Filed Nov 14, 2024
|
8 | $113.7M |
|
Q2 2024 13F
Filed Aug 9, 2024
|
8 | $102.8M |
|
Q1 2024 13F
Filed May 15, 2024
|
8 | $106.3M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
9 | $114.2M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
7 | $105.9M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
7 | $148.2M |
|
Q1 2023 13F
Filed May 15, 2023
|
8 | $151.2M |
|
Q4 2022 13F
Filed Feb 14, 2023
|
8 | $148.9M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
9 | $247.8M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
9 | $184.1M |
|
Q1 2022 13F
Filed May 18, 2022
|
10 | $210.7M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
13 | $326.9M |
4 earlier quarters on file — choose one from the quarter menu above.
Top 7 holdings · Q2 2023
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | NTRA NATERA INC | $42.9M | 28.95% |
| 2 | AKYA AKOYA BIOSCIENCES INC | $34.7M | 23.43% |
| 3 | GH GUARDANT HEALTH INC | $24.2M | 16.34% |
| 4 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | $20.3M | 13.72% |
| 5 | NSTG NANOSTRING TECHNOLOGIES INC | $11.0M | 7.45% |
| 6 | MXCT MAXCYTE INC | $8.7M | 5.84% |
| 7 | SONX SONENDO INC | $6.3M | 4.26% |
Values as reported on the Q2 2023 Form 13F. Every position is in the holdings table below.